INTRODUCTION
Medicinal herbs have always been used as traditional primary healthcare agents, especially in Asian countries. Over the last 20 years, rapid changes have been observed in the popular use of natural products from plant sources for maintainence of health and for alternative therapy, in Western countries. [1] Pereskia bleo and Pereskia grandifolia, commonly known as 'Jarum Tujuh Bilah' in Malaysia belong to the botanical family Cactaceae. Pereskia bleo can be easily confused with Pereskia grandifolia because they are vegetatively similar. However, they can be easily distinguished by the leaves, fl owers, and spines. Pereskia bleo has thinner, corrugated leaves, and orangish-red flowers, with shorter spines compared to Pereskia grandifolia. In contrast, Pereskia grandifolia has thicker, uncorrugated leaves, and pink to purplish-pink fl owers, with longer and lesser spines. [2] Both Pereskia bleo and Pereskia grandifolia have been used as natural remedies in cancer-related diseases, either eaten raw or taken as a concoction brewed from fresh plants. Both are believed to have anti-cancer, anti-tumor, anti-rheumatic, anti-ulcer, and anti-infl ammatory properties. They are also used as remedies for the relief of headache, gastric pain, ulcers, hemorrhoids, atopic dermatitis, and for revitalizing the body. [3] [4] [5] In Panama, the locals use the whole plant of Pereskia bleo to treat gastrointestinal problems, [6] while in India, Pereskia grandifolia is used to reduce swelling. [7] [8] Although Pereskia bleo and Pereskia grandifolia are reported to be used in a large number of Malaysian traditional medicine preparations, there is no published report on the study of acute oral toxicity of both Pereskia bleo and Pereskia grandifolia. The acute oral toxicity test is the simplest, and often the fi rst toxicity test to be conducted on a sample. A single, high dose of the test sample is given to each experimental animal and the mortality is observed; death within the observation period (usually of 14 days duration), whether caused by natural death or humane killing, is studied. [9] The fi ndings of this study corroborated the need for a safety study on both the Pereskia species used for primary health care in Malaysia. Such studies need to be carried out before the continued widespread use of some species provokes long-term and irreversible damage.
Previous cytotoxic investigations on Pereskia bleo [5, [10] [11] and Pereskia grandifolia [2] reported that both Pereskia bleo and Pereskia grandifolia had cytotoxic effects on various cancer cell lines, using in vitro cytotoxic activity assays, but did not show cytotoxicity against the normal cell line. [2, 11] If this also occurs in vivo, the use of this plant, by locals, for cancer treatment, would have scientifi c support.
MATERIALS AND METHODS

Plant sample collection and identifi cation
The fresh leaves of Pereskia bleo and Pereskia grandifolia were collected from Petaling Jaya, Selangor, Malaysia in September 2006 and February 2007, respectively. They were identifi ed by Professor Dr. Halijah Ibrahim of the Institute of Biological Sciences, Faculty of Science, University of Malaya, Malaysia, and voucher specimens were deposited in the herbarium of the Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia, with voucher numbers of SN01-06 (Pereskia bleo) and SN01-07 (Pereskia grandifolia).
Chemicals
Anhydrous sodium sulfate was purchased from the Sigma-Aldrich Company, while Tween 80 and methanol were obtained from the Merck Company.
Preparation of extracts
The crude extracts were prepared as previously described. [11] Briefl y, the fresh leaves of Pereskia bleo and Pereskia grandifolia were washed, dried, and ground to a fi ne powder, using a blender. The dried, ground leaves were then soaked in methanol (1.5 L) for three days, at room temperature. The solvent-containing extract was then decantered, dried with anhydrous sodium sulfate, and fi ltered. The extraction of the ground leaves was further repeated (2x) with methanol (1.5 L each time). The fi ltrates from each extraction were combined and the excess solvent was evaporated (Buchi, Rotavapor, Switzerland) under reduced pressure, using a rotary evaporator, to give a dark green crude methanol extract.
Test species
The experiment was performed on healthy ICR mice (fi ve weeks of age, body weight 23-28 g), obtained from the Laboratory Animal Center, Faculty of Medicine, University of Malaya. The female mice were confi rmed nulliparous and non-pregnant. The mice were assigned to fi ve dosage groups and one control group with 10 mice (fi ve male and fi ve female) for each test group. The weight variation in the mice used did not exceed Ϯ 20% SD of the mean body weight of each sex. The experimental procedures involving the animals were approved by the University of Malaya Animal Experimental Ethnics Committee [Ethical number: ISB/05/08/2009/SKS (R)] before commencing the study.
Procedure of acute oral toxicity
The acute oral toxicity of the crude methanol extracts of both the Pereskia species were evaluated in mice using the procedure described by the OECD (Organization for Economic Co-operation and Development), with some modifi cations. The mice were housed in suspended, stainless steel, wire-mesh cages in an experimental animal room. The temperature was maintained at 23 Ϯ 3°C and the relative humidity was 50-60% before and after treatment with the extract. The animal room was artifi cially illuminated (fl uorescent light) with an approximate 12-hour light/ dark cycle. The mice were acclimatized to the laboratory conditions for at least fi ve days prior to commencement of the experiments. The mice were randomly selected for use in the study and marked to provide individual identifi cation. Conventional mouse diets, with unlimited supply of drinking water, were available ad libitum, except during the fasting period. The mice were fasted approximately 12 hours prior to dosing, but they had free access to drinking water. Before and after treatment with the extract, the mice were caged in groups by sex and dose levels. The extracts were suspended in a vehicle (10% Tween-80 in distilled water). A stock concentration of 200 mg/ml was prepared and the mice were administrated with 0.2 ml of the extract for every 10 g of mice body weight. The mice were administered with doses of 500, 1000, 1500, 2000, and 2500 mg/kg of extracts. Food was started for the animals approximately three to four hours after dosing. The mice were observed carefully for any signs of toxicity in the fi rst four hours after the treatment period, and daily thereafter for a period of 14 days. Observations for mortality, signs of illness, injury, pain, distress, allergic reactions, changes of outer appearance, behavioral alterations (i.e., ataxia, hyperactivity, hypoactivity), and general stimulation or sedation were conducted twice daily. The observations were recorded systematically; individual records were maintained for each mouse.
RESULTS AND DISCUSSION
Extraction yield of Pereskia bleo and Pereskia grandifolia
Solvent extraction is the most popular method used in sample preparation. The yields from methanol extracts of Pereskia bleo and Pereskia grandifolia are shown in Table 1 . Before extraction, the plant material needs to be dried to avoid the presence of water in the extracts. The percentage of crude methanol extract yield is based on the weight of dried and ground plant materials. Methanol is used as the extraction solvent due to its polarity and its known ability to extract compounds such as, phenolics, fl avonoids, and other polar materials. [12] Acute oral toxicity assessment of Pereskia bleo and Pereskia grandifolia crude extracts Investigation of acute toxicity is the fi rst step in the toxicological analysis of herbal drugs. [13] Overall, animal models have a good predictability for human toxicities of around 70-80%. [14, 15] Generally, it is possible to get the fi rst hints on complex toxicities by applying in vivo methods, as information on some toxic manifestations cannot be assessed by in vitro cytotoxicity methods. [16] Toxic manifestations that affect the entire organism such as pain, distress, allergic reactions, changes in outer appearance, behavioral alterations, and general stimulation or sedation can be detected by in vivo assays. However, the detection of effects on vital functions (cardiovascular, central nervous, and respiratory systems) is usually not assessed in acute toxicity studies.
Acute oral toxicity was undertaken in the present study to determine the safety parameters of the leaves of Pereskia bleo and Pereskia grandifolia. Mortality, clinical signs, gross fi ndings, and body weights of mice were observed and measured for 14 days after the oral administration of crude methanol extracts to both Pereskia sp. The crude methanol extracts were used in this acute oral toxicity study to ensure that all components in the extract were included. Table 2 shows the results of the acute toxicity of the crude extracts of Pereskia bleo and Pereskia grandifolia. For all doses tested for crude methanol extracts of Pereskia bleo and Pereskia grandifolia, there were no deaths reported. Throughout the 14-day observation period, there were no signifi cant changes in behavior (i.e., ataxia, hyperactivity, hypoactivity) in any of the mice, nor did they produce any variations in the general appearance. They gained weight with no adverse clinical signs of toxicity at any dose.
Traditionally, the aim of the acute oral toxicity study was the estimation of LD 50 . The LD 50 value -defi ned as the statistically derived dose, which when administered in an acute toxicity test, is expected to cause death in 50% of the treated animals in a given period -is currently the basis for toxicological classifi cation of chemicals. For a classical LD 50 study, laboratory mice and rats are the species typically selected. Often both sexes must be used for regulatory purposes. [14] As no deaths were found for all doses tested for crude methanol extracts of Pereskia bleo and Pereskia grandifolia, the LD 50 values of crude P. bleo and P. grandifolia extracts were Ͼ2500 mg/kg. This indicated that both Pereskia sp. did not cause any acute toxicity. According to the chemical labeling and classification of acute systemic toxicity, based on oral LD 50 values, which were recommended by OECD, [17, 18] the crude extracts of both Pereskia sp. were assigned to class 5 (LD 50 Ͼ 2000 mg/kg), which was termed as the lowest toxicity class (no label; unclassifi ed). Oliver [19] pointed out that (i) the LD 50 value was not an absolute value, but was an inherently variable biological parameter that could not be described in terms of accuracy, but only of precision, (ii) the LD 50 value referred only to mortality and was illustrative of no other clinical expression of toxicity.
CONCLUSION
In view of the increasing popular consumption of medicinal plants as alternative therapy, it is necessary to conduct research to support the therapeutic claims and also to ensure that the plants are indeed safe for human consumption. The present research fi ndings have clearly met the objectives of the study. The result was in agreement with that of in vitro experiments, whereby, the crude extracts of Pereskia bleo and Pereskia grandifolia did not show cytotoxicity against normal MRC-5 cells. [2, 11] Based on the outcome of acute toxicity in experimental mice, the crude extracts of both Pereskia sp. could be regarded as safe in experimental mice. Further toxicity study over a longer period of time involving detection of effects on vital organ functions would ensure that the plants are safe for human consumption. 
